Stock MRK MERCK KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Merck KGaA

Equities

MRK

DE0006599905

Real-time Estimate Tradegate
Other stock markets
 15:59:55 02/05/2024 BST 		5-day change 1st Jan Change
149.9 EUR +0.65% Intraday chart for Merck KGaA -2.47% +3.99%
05-01 MERCK KGAA : Jefferies keeps its Buy rating ZD
04-29 Habeck's 'pharma trip' - industry sees structural problems DP

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
AQ
Merck's Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment
AQ
Merck : Prospectus - C-029771
PU
DD: Merck KGaA: Dr. Matthias Heinzel, buy
EQ
DD: Merck KGaA: Peter Guenter, buy
EQ
Merck KGaA, Darmstadt, Germany, Invests More than EUR 300 Million in New Life Science Production Site in Korea
AQ
AFR: Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQ
Biocytogen Launches RenBiologics, a Sub-Brand Focused on Out-Licensing Fully Human Antibodies for Therapeutic Development
AQ
Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid
AQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Veeva European Commercial Summit Gathers Life Sciences Industry Leading the Next Generation of Commercial Excellence
AQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Press Releases